Keywords: بیماری آلزایمر (AD); Shape-code; Multiplex detection; Alzheimer's disease (AD); Gold nanoparticles (AuNPs); Plasmonic biosensors; Localized surface plasmon resonance (LSPR);
مقالات ISI بیماری آلزایمر (AD) (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: بیماری آلزایمر (AD); Alzheimer's disease (AD); Circadian rhythm (CR); Sleep; Dim light at night (dLAN); Neurodegeneration; Drosophila melanogaster;
Keywords: بیماری آلزایمر (AD); Brain metabolism; Ketones; Acetoacetate; Glucose; Mild cognitive impairment (MCI); Alzheimer's disease (AD);
Keywords: بیماری آلزایمر (AD); Alzheimer's disease (AD); Mild cognitive impairment (MCI); Picture description task; Automatic assessment; Information coverage; Linguistic analysis; Phonetic features; Machine learning;
Keywords: بیماری آلزایمر (AD); Subjective Cognitive Decline (SCD); mild cognitive impairment (MCI); Major Depressive Disorder (MDD); cognitive decline; Alzheimer's Disease (AD);
Keywords: بیماری آلزایمر (AD); Adult-onset epilepsy; Dementia; Alzheimer's disease (AD); Dementia with Lewy bodies (DLB); Cerebrovascular disease (CVD);
Keywords: بیماری آلزایمر (AD); Alzheimer's disease (AD); Cerebrovascular disease; Lewy body disease; Frontotemporal degeneration; β-amyloid; Tau; α-Synuclein; TDP-43;
Keywords: بیماری آلزایمر (AD); Meta-analysis; Optical coherence tomography (OCT); Retinal thickness; Eye; Biomarkers; Alzheimer's disease (AD); Mild cognitive impairment (MCI);
Keywords: بیماری آلزایمر (AD); Alzheimer's disease (AD); Mild cognitive impairment (MCI); Quantitative susceptibility mapping (QSM); Gray matter volume;
Keywords: بیماری آلزایمر (AD); Alzheimer's disease (AD); Amylin challenge; Pramlintide; Safety; Diagnosis; Biomarkers;
Keywords: بیماری آلزایمر (AD); Mitochondria; Alzheimer's disease (AD); Gene expression; Blood; Biomarker; Mild cognitive impairment (MCI); Oxidative phosphorylation (OXPHOS);
Keywords: بیماری آلزایمر (AD); Apathy; Alzheimer's disease (AD); Mild behavioral impairment (MBI); neuropsychiatric symptoms (NPS); Neurocognitive disorders (NCD);
Keywords: بیماری آلزایمر (AD); Alzheimer's disease (AD); Amnestic mild cognitive impairment; Leukocyte telomere length; Telomere erosion;
Keywords: بیماری آلزایمر (AD); Personality changes; Cerebrospinal fluid biomarkers; Revised NEO Personality Inventory (NEO-PI-R); Alzheimer's disease (AD); Mild cognitive impairment (MCI);
Keywords: بیماری آلزایمر (AD); Mild cognitive impairment (MCI); Alzheimer's disease (AD); Multimodal neuroimaging data; Discriminative dictionary; Brain disorders;
Keywords: بیماری آلزایمر (AD); Metric learning; Alzheimer's Disease (AD); Mild Cognitive Impairment (MCI); SVM classifier; Feature fusion; Deep neural networks;
Keywords: بیماری آلزایمر (AD); Autoimmunity; Human papilloma virus (HPV); Alzheimer's disease (AD); Intra venous immunoglobulins (IVIG); Paraneoplastic neurological syndrome; Systemic lupus erythematosus (SLE); Anti-phospholipid syndrome (APS); Rheumatoid arthritis (RA); Anti-citrull
Keywords: بیماری آلزایمر (AD); Alzheimer's disease (AD); Positive affect; Quality of Life questionnaire for Dementia (QOL-D); Regional cerebral blood flow (rCBF);
Keywords: بیماری آلزایمر (AD); Appropriate use criteria (AUC); Positron emission tomography (PET); Amyloid; Alzheimer's disease (AD); Mild cognitive impairment (MCI);
Keywords: بیماری آلزایمر (AD); Posterior cortical atrophy (PCA); Alzheimer's disease (AD); Dyslexia; Letter-by-letter reading; Visual crowding;
Keywords: بیماری آلزایمر (AD); Antioxidant; Alzheimer's disease (AD); Glycation; Beta amyloid (Aβ); Neuroinflammation; Caenorhabditis elegans;
Keywords: بیماری آلزایمر (AD); Neurodegenerative diseases (ND); Alzheimer's disease (AD); Glycogen synthase Kinase-3 (GSK-3); Plaques; Tangles; Amyloid-beta
Keywords: بیماری آلزایمر (AD); DNA methylation; Biomarker; Epigenetics; Alzheimer's disease (AD); Blood; Type 2 diabetes; Dementia;
Keywords: بیماری آلزایمر (AD); Alzheimer's disease (AD); Diffuse Lewy body disease (DLB); Parkinson disease dementia (PDD); Cognition; Magnetic resonance imaging; Cholinergic Pathways Hyperintensities Scale (CHIPS);
Keywords: بیماری آلزایمر (AD); Alzheimer's disease (AD); Mild cognitive impairment (MCI); Multi-modality; Neuroimaging data; Sparse representation-based classification (SRC)
Keywords: بیماری آلزایمر (AD); Alzheimer's disease (AD); Aneuploidy; Genomic mosaicism; Cell cycle; Cohesion;
Keywords: بیماری آلزایمر (AD); Frontotemporal dementia; Lobar degeneration; Multiatlas mapping; Structural magnetic resonance imaging (MRI); Memory; Neuroanatomy; Primary progressive aphasia (PPA); Alzheimer's disease (AD)
Keywords: بیماری آلزایمر (AD); Meta-analysis; Aging; Alzheimer's disease (AD); Repetitive transcranial magnetic stimulation (rTMS); Transcranial direct current stimulation (tDCS); Cognitive function; Neuronal plasticity;
Keywords: بیماری آلزایمر (AD); TSP-1; Neuron-astrocyte crosstalk; Synaptic dysfunction; Aβ; Alzheimer's disease (AD);
Keywords: بیماری آلزایمر (AD); Mild cognitive impairment (MCI); Alzheimer's disease (AD); Electroencephalography (EEG); Magnetic resonance imaging (MRI); Gray matter density (GMD);
Keywords: بیماری آلزایمر (AD); Brain connectivity; Non-Euclidean wavelets; Multi-resolution analysis; Graph wavelets; Diffusion tensor imaging (DTI); Family history; Alzheimer's disease (AD);
Keywords: بیماری آلزایمر (AD); Alzheimer's disease (AD); Depression; Depressive symptom; Regional cerebral blood flow (rCBF)
Keywords: بیماری آلزایمر (AD); AD; Alzheimer's disease; Aβ; amyloid β; Aph-1; anterior pharynx defective 1; AP; adaptor protein; APOE; apolipoprotein E; APP; amyloid precursor protein; AICD; amyloid intracellular domain; BACE-1; β-secretase beta-site amyloid precursor protein-cleavi
Keywords: بیماری آلزایمر (AD); Dual-functional nanoparticles; Blood–brain barrier (BBB); Aβ1-42 peptide; Alzheimer's disease (AD)
Keywords: بیماری آلزایمر (AD); Alzheimer's disease (AD); Lipid rafts; Amyloid precursor protein (APP); Amyloid β (Aβ) peptide; α-, β-, γ-Secretases; Cellular prion protein (PrPC)
Keywords: بیماری آلزایمر (AD); DMN, default mode networkNormal aging; Alzheimer's disease (AD); Default mode network (DMN); Cerebral cortex; Hippocampus; Amyloid
Keywords: بیماری آلزایمر (AD); Alzheimer's disease (AD); Positron emission tomography (PET); Acetylcholinesterase (AChE) activity; Reserve;
Keywords: بیماری آلزایمر (AD); Insulin degrading enzyme (IDE); Alzheimer's disease (AD); Meta-analysis;
Keywords: بیماری آلزایمر (AD); Alzheimer's disease (AD); Consortium to Establish a Registry for Alzheimer's disease (CERAD); Geriatric Depression Scale (GDS); Voxel based morphometry (VBM);
Keywords: بیماری آلزایمر (AD); Alzheimer's disease (AD); Biomarker; Cerebrospinal fluid (CSF); Targeted proteomics; Multiple reaction monitoring (MRM); AD; Alzheimer's disease; CSF; cerebrospinal fluid; Aβ; amyloid beta; MS; mass spectrometry; 2DE; 2D gel electrophoresis; MALDI-TOF/TO
Keywords: بیماری آلزایمر (AD); Alzheimer's disease (AD); CacyBP/SIP; S100A6; Amyloidosis; Tau mice; Phosphatase activity;
Keywords: بیماری آلزایمر (AD); Posterior cortical atrophy (PCA); Alzheimer's disease (AD); Letter-by-letter reading; Pure alexia; Word form dyslexia;
Keywords: بیماری آلزایمر (AD); Alzheimer's Disease (AD); Computer Aided Diagnosis (CAD); Relative Entropy; Independent Component Analysis (ICA); Naive Bayes Classifier; Support Vector Machines (SVM); PET and SPECT;
Keywords: بیماری آلزایمر (AD); Mild Cognitive Impairment (MCI); Alzheimer's Disease (AD); Magnetic Resonance Spectroscopy (MRS); N-Acetyl Aspartate (NAA); Choline (Cho); Creatine (Cr); Myo-inositol (mI); Posterior cingulate; Hippocampus; Paratrigonal white matter;
Keywords: بیماری آلزایمر (AD); Alzheimer's disease (AD); Senile dementia; Chinese herbal medicine (CHM); Kidney-nourishing; Pharmacotherapy; Systematic review; Meta-analysis; Randomized controlled trial (RCT)
APOE DNA methylation is altered in Lewy body dementia
Keywords: بیماری آلزایمر (AD); Lewy body dementia (LBD); Alzheimer's disease (AD); DNA methylation; Apolipoprotein E (APOE); Differentially methylated region (DMR); Differential methylation; Postmortem brain; Human; Frontal lobe; Cerebellum; Pyrosequencing; Epigenetics; Dementia with L
CART peptide activates the Nrf2/HO-1 antioxidant pathway and protects hippocampal neurons in a rat model of Alzheimer's disease
Keywords: بیماری آلزایمر (AD); Alzheimer's disease (AD); Amyloid-beta (Aβ); Oxidative stress; Antioxidant; CART peptide; Nrf2;
High-throughput lipidomics characterize key lipid molecules as potential therapeutic targets of Kaixinsan protects against Alzheimer's disease in APP/PS1 transgenic mice
Keywords: بیماری آلزایمر (AD); Alzheimer's disease (AD); Kaixinsan (KXS); Lipidomics; APP/PS1 transgenic mice; Traditional Chinese medicine;
Predicting conversion from MCI to AD by integrating rs-fMRI and structural MRI
Keywords: بیماری آلزایمر (AD); Alzheimer's disease (AD); Mild cognitive impairment (MCI); Structural MRI; Resting-state fMRI; Graph theory; Machine learning approach;
Alzheimer's disease Archimedes condition-event simulator: Development and validation
Keywords: بیماری آلزایمر (AD); Alzheimer's disease (AD); Prodromal AD; Disease-modifying treatments; Simulation; Cost-effectiveness analysis; Biomarkers; Predictive equations;